A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2001
11/21/2001	CN1323207A Use of ophthalmic composition comprising vitamin A and vitamin E
11/21/2001	CN1323206A Fumaric acid microtablets
11/21/2001	CN1323205A Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders
11/21/2001	CN1323204A Remediesor preventives containing cyclopentenone compounds as the active ingredient
11/21/2001	CN1323203A FC receptor modulators and uses thereof
11/21/2001	CN1323202A Sertraline oral concentrate
11/21/2001	CN1323201A Extended release buccal bioadhesive tablet
11/21/2001	CN1323200A New oral formulation for 5-HT4 agonists or antagonists
11/21/2001	CN1323199A Liposome-entrapped topoisomerase inhibitors
11/21/2001	CN1323198A Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin
11/21/2001	CN1323194A UV protection compositions
11/21/2001	CN1323193A UV protection compositions
11/21/2001	CN1323186A Two chamber cartridge for atomizers
11/21/2001	CN1323161A Oral combination of lufenuron and nitenpyram against fleas
11/21/2001	CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof
11/21/2001	CN1322725A Indole derivant
11/21/2001	CN1322724A Isoflavane compound in spherophys and its medicine application
11/21/2001	CN1322721A New agarofuran derivatives and their prepn. medicine composition and use as medicine
11/21/2001	CN1322719A MYT1 kinase inhibitor
11/21/2001	CN1322572A Transforming growth factor-beta gene vaccine as diabetes and nephropathy preventing preparation
11/21/2001	CN1322566A Medicine for treating stomatopathy and throat disease
11/21/2001	CN1322557A Medicine for treating cardiac and cerebral vascular disease and hypertension and its preparation process
11/21/2001	CN1322555A Ointment for treating protrusion of lumber intervertebral disc and its preparation
11/21/2001	CN1322554A Cream for treating burns, scalds and sore ulcer and its preparation
11/21/2001	CN1322551A Preparation of toothache treating medicated gargle wine
11/21/2001	CN1322543A Preparation of antilipemic medicine
11/21/2001	CN1322536A Laxative and its preparation
11/21/2001	CN1322529A Application of double-stranded ribonucleic acid in preparing medicine for treating human Coxsackie virus infection
11/21/2001	CN1322528A Rhinitis treating medicine
11/21/2001	CN1322527A Dysentery treating medicine
11/21/2001	CN1322526A Compound for treating female sexual dysfunction
11/21/2001	CN1322525A Dehydrogenated falcate micromelum costusic alcohol derivative as medicine for preventing or treating cerebral retrogressive lesion
11/21/2001	CN1322524A Use of pentanoate derivant
11/21/2001	CN1075073C Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
11/21/2001	CN1075072C Oxazolidinone derivatives their preparation and use
11/21/2001	CN1075070C Substituted A2a-and diazacycloheptane and cyclooctane compounds and their use
11/21/2001	CN1075069C Synthesis of 3-[4-(2-aminoethoxy)-benzoyl)-2-aryl-6-hydroxybenzo(b) thiophenes
11/21/2001	CN1075067C Furan and furan amide compound and producing process and pharmaceutical composition thereof
11/21/2001	CN1075066C Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
11/21/2001	CN1075064C New benzoxazinedione derivatives, and producing process thereof and use
11/21/2001	CN1075063C Asymmetric synthesis of benzoxazinones compound
11/21/2001	CN1075062C 乙酸衍生物 Acetic acid derivatives
11/21/2001	CN1075059C Colchicine derivatives and its therapeutical use
11/21/2001	CN1074927C Active medical component of 'Duanshepiju' its extraction process and medicine containing the same
11/21/2001	CN1074926C Antiarrhythmic benzodiazepines
11/21/2001	CN1074925C Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
11/21/2001	CN1074924C Preparing method for medical composition containing 1,3-oxathiolane nucleoside analogues
11/21/2001	CN1074923C Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
11/21/2001	CN1074922C Oral liquid composition containing paroxetine resinate
11/21/2001	CN1074921C Use of N-alkyl derivatives of 1,5-dideoxy-1,5-imino-D-glucitol for the treatment of hepatitis B virus infections
11/21/2001	CN1074920C Analgesic agent and its use
11/21/2001	CN1074919C Application of levobupivacaine for treating chronic pain
11/21/2001	CN1074918C Use of Ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motion blockade
11/21/2001	CN1074917C Stable carotenoid emulsions adapted for parenteral administration
11/21/2001	CN1074898C Ionene polymers, producing process, its intermediate and use
11/20/2001	US6320074 In vivo modulation of lipid metabolism, skin-related processes, autoimmune diseases, fatty acid metabolism, malignant cell development, premalignant lesions, or programmed cell death
11/20/2001	US6320054 Thiazole derivatives
11/20/2001	US6320052 Crystalline precursors of 1-(((1(r)-(3-(2-(7-chloro-2-quino lynyl)ethenyl)phenyl)-3-(2-hydroxy-1-methyl-ethyl)phenyl) propyl)thio)methyl)cyclopropylacetic acid
11/20/2001	US6320051 Amino(nh) or oxygen(o) substituted, enzyme inhibitors of staphloccocus aureus methionyl t-rna synthetase (mrs); antibacterial agents
11/20/2001	US6320050 2-substituted phenyl-3-cycloalkyl substituted n-heteroaromatic propionamides; used to increase insulin secretion in the treatment of type ii diabetes.
11/20/2001	US6320047 Substituted aryl or heteroarylamides having retinoid-like biological activity
11/20/2001	US6320036 GbpA
11/20/2001	US6320022 Adrenomedullin peptides
11/20/2001	US6319957 Method for treating skin
11/20/2001	US6319956 N1, n4-bis(cyclopropylmethylamino)trialkylenetetramines that may be toluenesulfonated.
11/20/2001	US6319955 And a non-mek1 inhibitor anti-stroke agent selected from the group consisting of n-methyl-d-aspartate (nmda) receptor antagonists, immunosuppressants and caspase inhibitors
11/20/2001	US6319954 Administered to treat one or more withdrawal symptoms resulting from an addictive psychostimulant.
11/20/2001	US6319953 Provides preclinical screens for anxiolytic and antidepressant activity of nk-1 receptor antagonists.
11/20/2001	US6319951 Use of 3-amino-4-hydroxybenzoic acid for the treatment of retroviral infections
11/20/2001	US6319950 Formed by reacting an ester of ricinoleic acid with a tosyl chloride or a mesyl chloride and reacting said tosylate or mesylate of an ester of ricinoleic acid with diazabicycloundecene or diazabicyclononene
11/20/2001	US6319948 Retinoid antagonists and uses thereof
11/20/2001	US6319947 Vanadium (IV) metallocene complexes having spermicidal activity
11/20/2001	US6319945 Applying ivermectin lotion or cream daily for 7 days and repeating such application one to four times per month for a period of several months.
11/20/2001	US6319944 Nmda nr2b antagonists; neurological and neurodegenerative diseases including pain, (and in particular neuropathic pain), epilepsy, stroke, anxiety, cerebral ischemia, muscular spasms, alzheimer's, huntington's and parkinson's diseases
11/20/2001	US6319943 Oral formulation for paclitaxel
11/20/2001	US6319942 May be applied directly to scar tissue, or embedded in linaments held against the scars.
11/20/2001	US6319939 Retinoic acid mimetic anlides
11/20/2001	US6319938 Prophylactic or therapeutic drug for renal diseases
11/20/2001	US6319934 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium compounds
11/20/2001	US6319933 1-(1H-1,2,4-triazol-1-yl)butan-2-ol derivatives; fungicides
11/20/2001	US6319931 Use of a compound with affinity for the mitochondrial benzodiazepine receptor in cancer therapy
11/20/2001	US6319930 Substituted dimeric compounds
11/20/2001	US6319927 Method of using levocetirizine and pharmaceutical compositions containing the same for inducing sleep
11/20/2001	US6319926 Optically active 5H-pyrrolo[3, 4-B]pyrazine derivative, its preparation and pharmaceutical compositions containing it
11/20/2001	US6319924 For therapy of deleterious mental states
11/20/2001	US6319923 Method of treating a tumor
11/20/2001	US6319922 Propanoic acid derivatives
11/20/2001	US6319921 Aromatic heterocyclic compound as antiinflammatory agents
11/20/2001	US6319920 Muscarinic receptor antagonist used in gastrointestinal, genitourinary tract, respiratory tract, cardiovascular system, central nervous system disorders and in anesthesiology and ophthalmology
11/20/2001	US6319919 Inhibiting acetyl cholinesterase activity
11/20/2001	US6319917 Acylaminoalkenylene-amide derivatives as NK1 and NK2 antagonists
11/20/2001	US6319915 Benzazepine derivatives as inhibitors of hyperproliferation diseases
11/20/2001	US6319914 Administering polycyclic phenolic formulation dose to population of cells to confer cytoprotection
11/20/2001	US6319913 Penetration enhancing and irritation reducing systems
11/20/2001	US6319912 Administering daily dosage units of a progestational agent equal in progestational activity of levonogestrel, second phase of dosage of antiprogesin comprising benzisothiazoline derivative and third phase of placebo for contraception
11/20/2001	US6319911 Prevention of ovarian cancer by administration of progestin products
11/20/2001	US6319910 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
11/20/2001	US6319906 Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
11/20/2001	US6319904 Useful as an antiulcer agent, showing potent anti-helicobacter pylori activity
11/20/2001	US6319903 Anticonvulsant derivatives useful in treating cluster headaches

1 ... 5964 5965 5966 5967 5968 5969 5970 5971 5972 5973 5974 5975 5976 5977 5978 5979 5980 5981 5982 5983 5984 ... 7860